144 related articles for article (PubMed ID: 27477693)
1. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
Ki DH; He S; Rodig S; Look AT
Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
[TBL] [Abstract][Full Text] [Related]
3. PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor.
Perrone F; Da Riva L; Orsenigo M; Losa M; Jocollè G; Millefanti C; Pastore E; Gronchi A; Pierotti MA; Pilotti S
Neuro Oncol; 2009 Dec; 11(6):725-36. PubMed ID: 19246520
[TBL] [Abstract][Full Text] [Related]
4. p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.
Grit JL; McGee LE; Tovar EA; Essenburg CJ; Wolfrum E; Beddows I; Williams K; Sheridan RTC; Schipper JL; Adams M; Arumugam M; Vander Woude T; Gurunathan S; Field JM; Wulfkuhle J; Petricoin EF; Graveel CR; Steensma MR
Oncogene; 2024 May; 43(19):1411-1430. PubMed ID: 38480916
[TBL] [Abstract][Full Text] [Related]
5. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.
Carroll SL
Acta Neuropathol; 2012 Mar; 123(3):321-48. PubMed ID: 22160322
[TBL] [Abstract][Full Text] [Related]
7. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
Longo JF; Brosius SN; Black L; Worley SH; Wilson RC; Roth KA; Carroll SL
Cell Commun Signal; 2019 Jul; 17(1):74. PubMed ID: 31291965
[TBL] [Abstract][Full Text] [Related]
8. NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.
Dodd RD; Mito JK; Eward WC; Chitalia R; Sachdeva M; Ma Y; Barretina J; Dodd L; Kirsch DG
Mol Cancer Ther; 2013 Sep; 12(9):1906-17. PubMed ID: 23858101
[TBL] [Abstract][Full Text] [Related]
9. STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.
Somatilaka BN; Madana L; Sadek A; Chen Z; Chandrasekaran S; McKay RM; Le LQ
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38502231
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo.
Kohlmeyer JL; Kaemmer CA; Lingo JJ; Voigt E; Leidinger MR; McGivney GR; Scherer A; Koppenhafer SL; Gordon DJ; Breheny P; Meyerholz DK; Tanas MR; Dodd RD; Quelle DE
Neurooncol Adv; 2022; 4(1):vdac047. PubMed ID: 35571990
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.
Binobaid L; Masternak MM
Rep Pract Oncol Radiother; 2020; 25(4):556-561. PubMed ID: 32494228
[TBL] [Abstract][Full Text] [Related]
12. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis-a case report.
Ogasawara N; Yamashita S; Yamasaki K; Kawano T; Kawano T; Muta J; Matsumoto F; Watanabe T; Ohta H; Yokogami K; Fukushima T; Sato Y; Takeshima H
Brain Tumor Pathol; 2023 Oct; 40(4):222-229. PubMed ID: 37515639
[TBL] [Abstract][Full Text] [Related]
14. A genetic mouse model with postnatal
Inoue A; Janke LJ; Gudenas BL; Jin H; Fan Y; Paré J; Clay MR; Northcott PA; Hirbe AC; Cao X
Neurooncol Adv; 2021; 3(1):vdab129. PubMed ID: 34647023
[TBL] [Abstract][Full Text] [Related]
15. FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.
Voigt E; Quelle DE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686402
[TBL] [Abstract][Full Text] [Related]
16. Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.
Creus-Bachiller E; Fernández-Rodríguez J; Magallón-Lorenz M; Ortega-Bertran S; Navas-Rutete S; Romagosa C; Silva TM; Pané M; Estival A; Perez Sidelnikova D; Morell M; Mazuelas H; Carrió M; Lausová T; Reuss D; Gel B; Villanueva A; Serra E; Lázaro C
Mol Oncol; 2024 Apr; 18(4):895-917. PubMed ID: 37798904
[TBL] [Abstract][Full Text] [Related]
17. Mosaic zebrafish transgenesis for functional genomic analysis of candidate cooperative genes in tumor pathogenesis.
Ung CY; Guo F; Zhang X; Zhu Z; Zhu S
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867597
[TBL] [Abstract][Full Text] [Related]
18. Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumour with an NF1 Mutation Responding to Trametinib: A Case Report.
Hitchen N; Cross M; Laking G; Connor J; Korenbaum C
Case Rep Oncol; 2023; 16(1):1-6. PubMed ID: 36743881
[TBL] [Abstract][Full Text] [Related]
19. Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.
Ganapathy S; Fagman JB; Shen L; Yu T; Zhou X; Dai W; Makriyannis A; Chen C
Oncotarget; 2016 Dec; 7(51):84326-84337. PubMed ID: 27741517
[TBL] [Abstract][Full Text] [Related]
20. Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers.
Zhang G; Hoersch S; Amsterdam A; Whittaker CA; Lees JA; Hopkins N
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16940-5. PubMed ID: 20837522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]